Concomitant LAAC/AF Ablation (Watchman FLX Pro)
Recruiting
Observational Study
PFA Ablation and LAAC Procedures
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 120 (estimated)
- Sponsor
- Heart Rhythm Clinical and Research Solutions, LLC · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This sub-study is a prospective/retrospective, non-randomized, observational, comparative cohorts study, embedded in and expanding on the infrastructure of a real-world AF ablation registry DISRUPT-AF (NCT06335082).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria: All inclusion criteria of the main DISRUPT-AF registry will apply. In addition, patients included in this sub study must meet the additional inclusion criteria below:
* Patients who are determined by physicians to be eligible for LAAC
* Patients whose LAAC with Watchman FLX Pro …
Contacts